Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers
暂无分享,去创建一个
A. Leiser | S. Jabbour | G. Riedlinger | V. Subbiah | J. Malhotra | A. Silk | J. Mehnert | E. Girda | T. Chan | R. Groisberg | A. B. de Meritens | K. Spencer | R. Stephenson | T. Mayer | P. Popli | S. Ganesan | M. Palmeri | N. Chan | A.B. de Meritens